Kyowa Hakko has announced a new partnership with Wellex for its Cognizin citicoline ingredient.
The new partnership debuts with Creatine Well, a female-focused creatine product from Wellex featuring Cognizin, Pürest Creatine and Sharp-PS Phosphatidylserine.
The formula contains no sweeteners, flavours, caffeine, or fillers and delivers creatine as a micronised, fully dissolvable, unflavoured powder.
"Creatine Well represents a new way of thinking in women's supplementation," said Dr Katie Emerson, Senior Manager of Scientific Affairs at Kyowa Hakko USA.
"The decision to pair Cognizin and creatine by Dr Goldspink demonstrates a deep understanding of how these ingredients work together to support brain energy metabolism."
This formulation is the kind of clinically grounded, founder-led product that moves the supplement industry forward.
"Women don't need more supplements; they need better systems," Dr Goldspink, founder and Chief Innovation Officer of Wellex, added.
The wellness industry has become increasingly complex and optimisation-focused, but most meaningful health outcomes still come from supporting foundational systems consistently and intelligently.
Cognizin citicoline is backed by more than a decade of clinical research on its benefits for brain energy metabolism, cognitive performance and mental clarity.
Kyowa Hakko argues that the creatine product category has historically ignored the brain entirely and has instead solely marketed muscle performance, strength and exercise recovery, making the brain health angle a key differentiator for Creatine Well from other similar supplements in the category.